Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)

Ping Yen Liu, Cheng Huang Su, Feng Yu Kuo, Wen Lieng Lee, Yi Chih Wang, Wei Shiang Lin, Pao Hsien Chu, Tse Min Lu, Ping Han Lo, Cheng Han Lee, Wei Ren Lan, Chien Lung Huang, Shuji Tsukiyama, Wei Chen Yang, Li Chung Cheng, Virginia Rafael, Christian Nikolajsen, Wei Hsian Yin*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

A correction to this paper has been published: https://doi.org/10.1007/s12928-021-00779-2

Original languageEnglish
Pages (from-to)279-280
Number of pages2
JournalCardiovascular Intervention and Therapeutics
Volume37
Issue number2
DOIs
StatePublished - 04 2022

Bibliographical note

Publisher Copyright:
© 2021, Japanese Association of Cardiovascular Intervention and Therapeutics.

Fingerprint

Dive into the research topics of 'Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)'. Together they form a unique fingerprint.

Cite this